Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lerner

Showing results (71-80 of 439) with videos related to

Pageof 44
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Is There A Benefit of Restaging Transurethral Resection of Bladder Tumor Prior to Radical Cystectomy With or Without Neoadjuvant Chemotherapy?Justin P Mehr, Jenna N Bates, Seth P Lerner
Current Opinion in Urology|December 20, 2007
Molecular markers in bladder cancerShahrokh F Shariat, Jose A Karam, Seth P Lerner
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 1, 1997
Recurrent intracerebral hemorrhage from sarcoid angiitisR B Libman, S Sharfstein, W Harrington, et al.
Obstetrical & Gynecological Survey|December 1, 1996
Use of transvaginal sonography in the evaluation of endometrial hyperplasia and carcinomaJ P Lerner, I E Timor-Tritsch, A Monteagudo
The Journal of Urology|March 1, 1989
Infection stonesS P Lerner, M J Gleeson, D P Griffith
Urologic Oncology|July 5, 2011
A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinomaJonathan M Levitt, Weiguo Jian, Seth P Lerner, et al.
Anticancer Research|April 13, 2001
Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survivalM Younes, D Juarez, L V Lechago, et al.
Molecular Genetics and Metabolism|May 23, 2006
Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observationsChantal F Morel, Jordan P Lerner-Ellis, David S Rosenblatt
Anticancer Research|July 2, 2014
The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinomaWeiguo Jian, Jonathan M Levitt, Seth P Lerner, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Therapeutic Effect on Bladder Cancer with a Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex VirusKwan Joong Joo, Hongtao Li, Xiaoliu Zhang, et al.
Pageof 44

Showing results (71-80 of 439) with videos related to

Sort By:
Pageof 44
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Is There A Benefit of Restaging Transurethral Resection of Bladder Tumor Prior to Radical Cystectomy With or Without Neoadjuvant Chemotherapy?Justin P Mehr, Jenna N Bates, Seth P Lerner
Current Opinion in Urology|December 20, 2007
Molecular markers in bladder cancerShahrokh F Shariat, Jose A Karam, Seth P Lerner
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 1, 1997
Recurrent intracerebral hemorrhage from sarcoid angiitisR B Libman, S Sharfstein, W Harrington, et al.
Obstetrical & Gynecological Survey|December 1, 1996
Use of transvaginal sonography in the evaluation of endometrial hyperplasia and carcinomaJ P Lerner, I E Timor-Tritsch, A Monteagudo
The Journal of Urology|March 1, 1989
Infection stonesS P Lerner, M J Gleeson, D P Griffith
Urologic Oncology|July 5, 2011
A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinomaJonathan M Levitt, Weiguo Jian, Seth P Lerner, et al.
Anticancer Research|April 13, 2001
Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survivalM Younes, D Juarez, L V Lechago, et al.
Molecular Genetics and Metabolism|May 23, 2006
Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observationsChantal F Morel, Jordan P Lerner-Ellis, David S Rosenblatt
Anticancer Research|July 2, 2014
The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinomaWeiguo Jian, Jonathan M Levitt, Seth P Lerner, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Therapeutic Effect on Bladder Cancer with a Conditionally Replicating Oncolytic Virus Derived from Type II Herpes Simplex VirusKwan Joong Joo, Hongtao Li, Xiaoliu Zhang, et al.
Pageof 44